|
| | Range
(Min.–Max. value) | Mean value | Percentage increase in comparison to control group |
|
| Retropharyngeal space (Mp-Lp) in mm | Edentulous subjects (control group) | 6.59–20.18 | 11.97 | 0% |
| First interventional group | 9.64–22.32 | 14.14 | 18.12% |
| Second interventional group | 12.73–22.78 | 16.90 | 41.18% |
|
| Posterior airway space in mm | Edentulous subjects (control group) | 6.08–23.07 | 12.63 | 0% |
| First interventional group | 7.98–24.96 | 14.50 | 14.80% |
| Second interventional group | 12.59–26.06 | 17.10 | 35.39% |
|
| apw2-ppw2 in mm | Edentulous subjects (control group) | 8.98–22.15 | 13.55 | 0% |
| First interventional group | 9.92–24.39 | 15.75 | 16.23% |
| Second interventional group | 14.95–25.48 | 18.67 | 37.78% |
|
| apw4-ppw4 in mm | Edentulous subjects (control group) | 10.56–26.44 | 18.74 | 0% |
| First interventional group | 12.56–27.07 | 20.33 | 8.48% |
| Second interventional group | 14.08–31.97 | 22.01 | 17.44% |
|
| FVC in % predicted | Edentulous subjects (control group) | 54–98 | 76.75 | 0% |
| First interventional group | 63–98 | 77.35 | 0.78% |
| Second interventional group | 60–97 | 77.95 | 1.56% |
|
| Fev1 in % predicted | Edentulous subjects (control group) | 54–101 | 76.30 | 0% |
| First interventional group | 48–103 | 77.40 | 1.44% |
| Second interventional group | 44–91 | 77.15 | 1.11% |
|
| Fev1% in % predicted | Edentulous subjects (control group) | 59–114 | 94.40 | 0% |
| First interventional group | 62–111 | 94.80 | 0.42% |
| Second interventional group | 64–111 | 94.80 | 0.42% |
|
| PIFR in L/sec | Edentulous subjects (control group) | 1.43–3.75 | 2.39 | 0% |
| First interventional group | 1.51–4.84 | 2.93 | 22.59% |
| Second interventional group | 1.54–5.24 | 3.29 | 37.65% |
|
